ArticlePituitary2020
The tale in evolution: clarity, consistency and consultation, not contradiction and confusion.
Article in Pituitary, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 1 synthesis or guideline pooled it.
- Consensus guideline for the diagnosis and management of pituitary adenomas in childhood and adolescence: Part 1, general recommendations.Nature reviews. Endocrinology · 2024Guideline
- The PitNET Puzzle: From Zero to Linking Molecular Behavior with Neurosurgical Aspects.Medicina (Kaunas, Lithuania) · 2025Review
- Pituitary adenomas: biology, nomenclature and clinical classification.Reviews in endocrine & metabolic disorders · 2025Review
- Clinical Biology of the Pituitary Adenoma.Endocrine reviews · 2022Review
- The NETting of pituitary adenoma: a gland illusion.Pituitary · 2022Article
- Epigenetic and post-transcriptional regulation of somatostatin receptor subtype 5 (SSTMolecular oncology · 2022Article
- Pituitary adenoma…nomen omen?Endocrine · 2021Article
- Classification of neuroendocrine neoplasms: lights and shadows.Reviews in endocrine & metabolic disorders · 2021Review
- Pituitary adenoma or pituitary neuroendocrine tumor: a narrative review of controversy and perspective.Translational cancer research · 2021Review
- Genetics of Acromegaly and Gigantism.Journal of clinical medicine · 2021Review
- Pituitary Neoplasm Nomenclature Workshop: Does Adenoma Stand the Test of Time?Journal of the Endocrine Society · 2021Article
- Prospective Evaluation of Incidental Pituitary Imaging Findings in the Sella Turcica.Journal of the Endocrine Society · 2021Article
- Best Achievements in Pituitary and Adrenal Diseases in 2020.Endocrinology and metabolism (Seoul, Korea) · 2021Review
- Novel Insights into Pituitary Tumorigenesis: Genetic and Epigenetic Mechanisms.Endocrine reviews · 2020Review
- Are aggressive pituitary tumors and carcinomas two sides of the same coin? Pathologists reply to clinician's questions.Reviews in endocrine & metabolic disorders · 2020Review
Corrections and comments
- Comment on
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
31912348What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.